Partnership

AREA OF PARTNERING INTEREST

We are looking for partners to collaborate with us on

• Drugs co-development
• Invest in our clinical trials

We can help you with

• US regulatory submission.
• China regulatory submission and drugs commercialization.

Other areas of interest

• In-licensing.
• Out-licensing

Click here to see our pipelines.

COLLABORATION OPPORTUNITIES IN CHINA

Tasly in China is one of China’s largest publicly listed pharmaceutical companies (Shanghai:
SHSE:600535), with over 19,000 employees and more than 40 subsidiaries globally. In China,
we have one of the most significant sales forces and teams with China FDA compliant clinical
and regulatory capabilities. Besides license-in drugs into China, we provide comprehensive
services in

• Regulatory submission/registration
• Research and development consultation
• Other related areas